Collegium Pharmaceutical, Inc. (COLL)

23.53 -0.17 (-0.72%) USD  |  NASDAQ  |  Sep 04, 16:00
23.52 -0.01 (-0.04%) After-Hours: 20:00
More

Collegium Pharmaceutical SG&A Expense (TTM) : 327.69M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 327.69M
March 31, 2026 294.73M
December 31, 2025 284.80M
September 30, 2025 280.25M
June 30, 2025 275.11M
March 31, 2025 244.80M
December 31, 2024 210.36M
September 30, 2024 180.21M
June 30, 2024 153.56M
March 31, 2024 148.42M
December 31, 2023 159.21M
September 30, 2023 164.30M
June 30, 2023 167.37M
March 31, 2023 170.43M
December 31, 2022 172.19M
September 30, 2022 160.76M
June 30, 2022 152.90M
March 31, 2022 142.01M
December 31, 2021 118.96M
September 30, 2021 119.18M
June 30, 2021 115.09M
March 31, 2021 114.05M
December 31, 2020 113.83M
Date Value
September 30, 2020 112.10M
June 30, 2020 115.74M
March 31, 2020 115.36M
December 31, 2019 116.45M
September 30, 2019 121.81M
June 30, 2019 125.19M
March 31, 2019 127.53M
December 31, 2018 126.76M
September 30, 2018 121.40M
June 30, 2018 110.71M
March 31, 2018 101.49M
December 31, 2017 92.76M
September 30, 2017 93.03M
June 30, 2017 93.84M
March 31, 2017 91.95M
December 31, 2016 80.63M
September 30, 2016 63.17M
June 30, 2016 45.51M
March 31, 2016 28.27M
December 31, 2015 18.93M
September 30, 2015 11.03M
June 30, 2015 5.119M
March 31, 2015 2.185M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Innoviva, Inc. 126.42M
Zevra Therapeutics, Inc. 74.63M
Supernus Pharmaceuticals, Inc. 560.88M
Indivior Pharmaceuticals, Inc. 591.00M
Crinetics Pharmaceuticals, Inc. 214.37M